A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
100

High-Sensitivity Cardiac Troponin I Levels and Prediction of Heart Failure: Results From the BiomarCaRE Consortium.
Isabell Yan, Christin S Börschel, Johannes T Neumann, Ngoc A Sprünker, Nataliya Makarova, Jukka Kontto, Kari Kuulasmaa, Veikko Salomaa, Christina Magnussen, Licia Iacoviello,[...]. JACC Heart Fail 2020
12
100

Impact of diabetes on the predictive value of heart failure biomarkers.
Nuria Alonso, Josep Lupón, Jaume Barallat, Marta de Antonio, Mar Domingo, Elisabet Zamora, Pedro Moliner, Amparo Galán, Javier Santesmases, Cruz Pastor,[...]. Cardiovasc Diabetol 2016
31
100

Disruption of energy utilization in diabetic cardiomyopathy; a mini review.
Shinsuke Nirengi, Carmem Peres Valgas da Silva, Kristin I Stanford. Curr Opin Pharmacol 2020
4
100

Microalbuminuria and cardiovascular risk.
Janaka Karalliedde, Giancarlo Viberti. Am J Hypertens 2004
94
100

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
157
100

A prospective cohort study of home blood pressure monitoring based on an intelligent cloud platform (the HBPM-iCloud study): rationale and design.
Hailan Zhu, Xiaoyan Liang, Xiong-Fei Pan, Chunyi Huang, Jian Kuang, Weibiao Lv, Qingchun Zeng, Weiyi Mai, Yuli Huang. Ther Adv Chronic Dis 2020
5
100

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Michael R MacDonald, Mark C Petrie, Fumi Varyani, Jan Ostergren, Eric L Michelson, James B Young, Scott D Solomon, Christopher B Granger, Karl Swedberg, Salim Yusuf,[...]. Eur Heart J 2008
368
100

Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
Tevfik Sabuncu, Alper Sonmez, Mehmet Ali Eren, Ibrahim Sahin, Demet Çorapçioğlu, Rıfkı Üçler, Şafak Akin, Cem Haymana, İbrahim Demirci, Ayşegül Atmaca,[...]. Prim Care Diabetes 2021
2
100

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.
Toshiaki Ohkuma, Min Jun, Mark Woodward, Sophia Zoungas, Mark E Cooper, Diederick E Grobbee, Pavel Hamet, Giuseppe Mancia, Bryan Williams, Paul Welsh,[...]. Diabetes Care 2017
23
100

Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial.
Jawad H Butt, Kieran F Docherty, Mark C Petrie, Morten Schou, Mikhail N Kosiborod, Eileen O'Meara, Tzvetana Katova, Charlotta E A Ljungman, Mirta Diez, Modele O Ogunniyi,[...]. JAMA Cardiol 2021
4
100

Heart Failure in Type 2 Diabetes Mellitus.
Helena C Kenny, E Dale Abel. Circ Res 2019
151
100

Diabetes and cardiorenal syndrome: Understanding the "Triple Threat".
Srikanta Banerjee, Raymond Panas. Hellenic J Cardiol 2017
9
100

Mitophagy in Diabetic Cardiomyopathy: Roles and Mechanisms.
Haoxiao Zheng, Hailan Zhu, Xinyue Liu, Xiaohui Huang, Anqing Huang, Yuli Huang. Front Cell Dev Biol 2021
4
100

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
358
100


On the prognostic value of post-load glucose in patients with coronary artery disease.
Lars Rydén, Bahira Shahim, Eberhard Standl. Eur Heart J 2018
10
100

Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitus.
David J Holland, Thomas H Marwick, Brian A Haluska, Rodel Leano, Matthew D Hordern, James L Hare, Zhi You Fang, Johannes B Prins, Tony Stanton. Heart 2015
87
100

Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.
Raphael Wurm, Michael Resl, Stephanie Neuhold, Rudolf Prager, Helmut Brath, Claudia Francesconi, Greisa Vila, Guido Strunk, Martin Clodi, Anton Luger,[...]. Heart 2016
11
100

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Rev Esp Cardiol (Engl Ed) 2016
235
100

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.
Roberto Latini, Serge Masson, Maylene Wong, Simona Barlera, Elisa Carretta, Lidia Staszewsky, Tarciso Vago, Aldo P Maggioni, Inder S Anand, Lip B Tan,[...]. Am J Med 2006
88
100

Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
Alberto Aimo, James L Januzzi, Giuseppe Vergaro, Andrea Ripoli, Roberto Latini, Serge Masson, Michela Magnoli, Inder S Anand, Jay N Cohn, Luigi Tavazzi,[...]. Circulation 2018
95
100

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
Benjamin M Scirica, Eugene Braunwald, Itamar Raz, Matthew A Cavender, David A Morrow, Petr Jarolim, Jacob A Udell, Ofri Mosenzon, KyungAh Im, Amarachi A Umez-Eronini,[...]. Circulation 2014
407
100

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
100

Free fatty acids are associated with metabolic syndrome and insulin resistance but not inflammation in systemic lupus erythematosus.
M J Ormseth, L L Swift, S Fazio, M F Linton, P Raggi, J F Solus, A Oeser, A Bian, T Gebretsadik, A Shintani,[...]. Lupus 2013
31
100

Is epicardial fat tissue a marker of metabolic syndrome in obese children?
Artur Mazur, Mariusz Ostański, Grzegorz Telega, Ewa Malecka-Tendera. Atherosclerosis 2010
25
100

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Aidin Rawshani, Araz Rawshani, Stefan Franzén, Naveed Sattar, Björn Eliasson, Ann-Marie Svensson, Björn Zethelius, Mervete Miftaraj, Darren K McGuire, Annika Rosengren,[...]. N Engl J Med 2018
437
100

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
Gerasimos Filippatos, Stefan D Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P Maggioni, Piotr Ponikowski, Adriaan A Voors, Faiez Zannad,[...]. Eur Heart J 2016
150
100

Trends in prevalence and outcome of heart failure with preserved ejection fraction.
Theophilus E Owan, David O Hodge, Regina M Herges, Steven J Jacobsen, Veronique L Roger, Margaret M Redfield. N Engl J Med 2006
100

Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
Kåre I Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal-Pantaler,[...]. Diabetes Obes Metab 2020
28
100

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Mark H Drazner, Gregg C Fonarow, Stephen A Geraci, Tamara Horwich, James L Januzzi,[...]. Circulation 2013
100

Clinical applications for out-of-office blood pressure monitoring.
Hailan Zhu, Haoxiao Zheng, Xinyue Liu, Weiyi Mai, Yuli Huang. Ther Adv Chronic Dis 2020
7
100

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.
Mark Ledwidge, Joseph Gallagher, Carmel Conlon, Elaine Tallon, Eoin O'Connell, Ian Dawkins, Chris Watson, Rory O'Hanlon, Margaret Bermingham, Anil Patle,[...]. JAMA 2013
290
100

Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Guanghong Jia, Michael A Hill, James R Sowers. Circ Res 2018
448
100

Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08).
Erland Erdmann, Bernard Charbonnel, Robert G Wilcox, Allan M Skene, Massimo Massi-Benedetti, John Yates, Meng Tan, Robert Spanheimer, Eberhard Standl, John A Dormandy. Diabetes Care 2007
203
100

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, Sophia Zoungas, Avinesh Pillai, Meg Jardine, Anushka Patel, Alan Cass, Bruce Neal, Neil Poulter,[...]. J Am Soc Nephrol 2009
595
100

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
Faiez Zannad, João Pedro Ferreira, Stuart J Pocock, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Martina Brueckmann, Anne Pernille Ofstad, Egon Pfarr, Waheed Jamal,[...]. Lancet 2020
251
100

Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis.
Cucnhat Walker, Subrata Deb, Hua Ling, Zhe Wang. J Pharm Pharm Sci 2020
6
100

Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited.
Alexandre A da Silva, Jussara M do Carmo, Xuan Li, Zhen Wang, Alan J Mouton, John E Hall. Can J Cardiol 2020
24
100

Cardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials.
Islam Y Elgendy, Ahmed N Mahmoud, Amr F Barakat, Akram Y Elgendy, Marwan Saad, Ahmed Abuzaid, Siddarth A Wayangankar, Anthony A Bavry. Am J Cardiovasc Drugs 2017
29
100


Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
100

PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.
Martin Huelsmann, Stephanie Neuhold, Michael Resl, Guido Strunk, Helmut Brath, Claudia Francesconi, Christopher Adlbrecht, Rudolf Prager, Anton Luger, Richard Pacher,[...]. J Am Coll Cardiol 2013
146
100



2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz,[...]. Circulation 2017
100

Repeat measurements of glycated haemoglobin A(1c) and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus.
Stephanie Neuhold, Michael Resl, Martin Huelsmann, Guido Strunk, Christopher Adlbrecht, Claus Rath, Rudolf Prager, Anton Luger, Martin Clodi, Richard Pacher. Eur J Clin Invest 2011
6
100

The emerging epidemic of heart failure with preserved ejection fraction.
A Afşin Oktay, Jonathan D Rich, Sanjiv J Shah. Curr Heart Fail Rep 2013
163
100

Diabetic Cardiomyopathy as a Clinical Entity: Is It a Myth?
Mitul P Zaveri, Jamal C Perry, Tayná M Schuetz, Mohammad D Memon, Sadaf Faiz, Ivan Cancarevic. Cureus 2020
3
100

Epidemiology of heart failure.
Amy Groenewegen, Frans H Rutten, Arend Mosterd, Arno W Hoes. Eur J Heart Fail 2020
104
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.